CanBas Competitors and Similar CompaniesClear all
CanBas's competitors and similar companies include CureVac, Tosk, Polaris Pharmaceuticals and EPICS Therapeutics.
 CanBas CanBas (キャンバス) is a drug discovery company engaged in research and development of anti-cancer agents. |  Tosk Tosk is a biopharmaceutical company that provides drug development solutions for cancer treatment. |  Polaris Pharmaceuticals Polaris Pharmaceuticals is a biopharmaceutical drug company focused on developing anti-cancer therapies. |  EPICS Therapeutics EPICS Therapeutics is a drug discovery company dedicated to creating medicines in oncology. | ||
Founding Date | Founding Date 2000 | Founding Date 2000 | Founding Date 2008 | Founding Date 2006 | Founding Date 2018 |
Type | Type Public | Type Public | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations HQ | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations Mountain View, US HQ Sunnyvale, US | Locations San Diego, US HQ Vacaville, US | Locations Charleroi, BE HQ Paris, FR |
Employees | Employees 13 | Employees 82517% decrease | Employees 109% decrease | Employees 26 | Employees 28 |
Valuation ($) | Valuation ($) 109.6 m | Valuation ($) 648.3 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €535.2m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods €9.7m (FY, 2024) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit €534.4m (FY, 2024) | Gross profit N/A | Gross profit N/A | Gross profit N/A |
Net income | Net income (¥1.2b) (FY, 2025) | Net income €162.2m (FY, 2024) | Net income N/A | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 3.1m (about 10 years ago) | Latest funding round N/A | Latest funding round $ 8.4m (about 8 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 1.1b | Total funding raised $ 8.6m | Total funding raised N/A | Total funding raised $ 8.4m |
For sources of this data, please see the company profile
View Company Profiles
CureVac
HQ
Tübingen, DE
Employees
825↓ 17% decrease
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View companyTosk
HQ
Mountain View, US
Employees
10↓ 9% decrease
Tosk is a biopharmaceutical company that provides drug development solutions for cancer treatment.
View companyPolaris Pharmaceuticals
HQ
San Diego, US
Employees
26
Polaris Pharmaceuticals is a biopharmaceutical drug company focused on developing anti-cancer therapies.
View companyEPICS Therapeutics
HQ
Charleroi, BE
Employees
28
EPICS Therapeutics is a drug discovery company dedicated to creating medicines in oncology.
View company